Lobectomy should remain the first choice for treating early stage nonsmall cell lung cancer

HY Deng, Q Zhou - European Respiratory Journal, 2019 - Eur Respiratory Soc
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy, is
characterised as a highly noninvasive precise radiotherapy that is performed by applying an …

Surgery or stereotactic body radiotherapy for early-stage lung cancer: two sides of the same coin?

L Berzenji, PE Van Schil - European Respiratory Journal, 2019 - Eur Respiratory Soc
Currently, the standard of care for resectable, early-stage and functionally operable
nonsmall cell lung cancer (NSCLC) is complete surgical resection [1]. However, for elderly …

[HTML][HTML] Stereotactic body radiation therapy versus surgery for early stage non-small cell lung cancer: clearing a path through an evolving treatment landscape

JI Choi, CB Simone - Journal of Thoracic Disease, 2019 - ncbi.nlm.nih.gov
These findings largely mirror the bulk of available literature on this topic. Surgical resection
with lobectomy and mediastinal sampling was established as the primary treatment and …

[HTML][HTML] Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?

L Bertolaccini, A Terzi, F Ricchetti… - Annals of Translational …, 2015 - ncbi.nlm.nih.gov
Lung neoplasm is the most influent cause of death for cancer. With the increasing of life
expectancy in elderly patients and with the intensification of lung cancer screening by low …

Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future

M Hamaji - General Thoracic and Cardiovascular Surgery, 2020 - Springer
Stereotactic body radiotherapy (SBRT) may be a potential alternative to surgical resection in
high-risk operable patients with early-stage non-small cell lung cancer (NSCLC). A number …

[HTML][HTML] What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer?

M Guckenberger - Journal of Thoracic Disease, 2011 - ncbi.nlm.nih.gov
Non-small cell lung cancer, if detected at early stage, is a disease with high probability for
cure. However, the treatment in clinical practice is highly dependent on the co-morbidities of …

The American Society of Clinical Oncology–endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early …

M Guckenberger, JG Aerts, P Van Schil… - The Journal of thoracic …, 2019 - jtcvs.org
Feature Editor's Note—After reading this Feature Expert Opinion, it should be more evident
than ever that lobectomy is the current standard of care for patients with stage I non–small …

[HTML][HTML] Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?

K Mullins - Journal of the Advanced Practitioner in Oncology, 2015 - ncbi.nlm.nih.gov
Lung cancer, the second most frequently diagnosed malignancy for men and women in the
United States, will account for an estimated 221,200 newly diagnosed cases and 158,040 …

Survival outcome after stereotactic body radiation therapy and surgery for early stage non-small cell lung cancer: a meta-analysis

XJ Yu, WR Dai, Y Xu - Journal of Investigative Surgery, 2018 - Taylor & Francis
Objective: Treatment modalities in medically compromised patients with early-stage non-
small cell lung cancer (NSCLC) are controversial. Stereotactic body radiotherapy (SBRT) or …

Stereotactic ablative radiotherapy as an alternative to lobectomy in patients with medically operable stage I NSCLC: a retrospective, multicenter analysis

V Scotti, A Bruni, G Francolini, M Perna, P Vasilyeva… - Clinical lung cancer, 2019 - Elsevier
Background Stereotactic ablative body radiation therapy (SBRT) has evolved as the
standard treatment for patients with inoperable stage I non–small-cell lung cancer (NSCLC) …